News

UK National Screening Committee backs CVD screening

06-Mar-08

Gordon Brown
The DoH is determining if its national cardiovascular disease (CVD) screening programme is feasible, despite prime minister Gordon Brown announcing the plans in January.

The UK National Screening Committee (NSC) has released guidance on how CVD screening would operate.

For an average practice of 6,000 patients, this would result in 140 half-an-hour screening sessions per year, equivalent to three to four per week. 

The NSC's latest report says a population-wide screening programme is feasible, ‘even in the most deprived inner-city practices'.

The evidence recommends conducting a vascular risk assessment on all patients aged 40-74, every five years. 

The NSC calculates that the average practice would diagnose four new cases of diabetes mellitus and 17 new diagnoses of impaired glucose regulation per year.

Mr Brown suggested in January that screening for CVD, diabetes, chronic kidney disease, stroke risk and chronic lung diseases would become available to anyone. 

A DoH spokeswoman said economic modelling work to look at the feasibility of vascular risk screening is underway.

But Professor Richard Hobbs, chairman of the Primary Care Cardiovascular Society, said: ‘It would be more appropriate to get a high-risk screening programme off the ground first, and then see if a national programme could be cost-effective.' 

GPC deputy chairman Dr Richard Vautrey said CVD screening would require a significant increase in GP workload and resources.

tom.ireland@haymarket.com

Comment below and tell us what you think

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Healthcare Republic Forums

 

Registrar

Professional development - Membership of the RCGP

Dr Sathya Naidoo explains the criteria that are required for completing iMAP. Read more

How to apply for your certificate

Applying to the RCGP for your CCT recommendation now takes three clicks, writes Fiona Erasmus. Read more

A question of capacity

Medicolegal advisor, Dr John Holden addresses some dilemmas on consent that may be faced by GPs. Read more

Show all articles

 

Latest Clinical Articles

Stable angina pectoris

Section 1 Definition and pathophysiology Read more

Endometriosis

Contributed by Mr Michael Booker, consultant obstetrician & gynaecologist, and fertility specialist ... Read more

Primary hyperparathyroidism

Contributed by Mr David Scott-Coombes, consultant endocrine surgeon at the University Hospital of Wa... Read more

Show all clinical articles

MIMS Product News

Toviaz

New drug - Toviaz

Pfizer has launched Toviaz (fesoterodine), a once-daily treatment for the symptoms of overactive bla... Read more

New drug - Tasigna

Novartis has launched Tasigna (nilotinib), a new antineoplastic agent for Philadelphia chromosome po... Read more

Ciproxin licensed for UTI in children

The licence for Ciproxin (ciprofloxacin) has been extended to include the second- and third-line tr... Read more

Jobs

 

Job of the Week